Pumpinheart is a heart failure treatment system with preserved ejection fraction (HFpEF).
Pumpinheart has raised $832K in total funding. The most recent round was Seed. The last funding was announced in February 2026.
Pumpinheart's investors include MedTech Innovator.
Pumpinheart is headquartered in Blackrock, Ireland.
Pumpinheart is a heart failure treatment system with preserved ejection fraction (HFpEF).
Pumpinheart is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pumpinheart — Funding & Investors." VCBacked, February 10, 2026, https://www.vcbacked.co/company/pumpinheart. Accessed September 15, 2026.
VCBacked. (2026). Pumpinheart — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/pumpinheart
{{cite web |title=Pumpinheart — Funding & Investors |url=https://www.vcbacked.co/company/pumpinheart |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated